HLS Therapeutics Inc.
HLS
Classifica tra le azioni
#21998
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Prezzo delle azioni
$2.94
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$90.88M
Variazione (1 giorno)
-0.48%
Variazione (1 anno)
-26.92%
Paese
CA
Scambia HLS Therapeutics Inc. (HLS)
Categoria
Healthcare
Storico del prezzo dell'azione per HLS Therapeutics Inc. (HLS)
Prezzo di chiusura più alto: $2.76 il 2026-10-01
Prezzo di chiusura più basso: $0.42 il 2010-01-01
Prezzo di chiusura più basso: $0.42 il 2010-01-01
Storico del prezzo dell'azione di HLS Therapeutics Inc. dal 2010 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -6.31% |
| 2025 | 36.44% |
| 2024 | -11.68% |
| 2023 | -61.22% |
| 2022 | -36.61% |
| 2021 | -14.29% |
| 2020 | -5.41% |
| 2019 | 23.57% |
| 2018 | 504.45% |
| 2017 | 5.61% |
| 2016 | -1.13% |
| 2015 | 1.31% |
| 2014 | -15.58% |
| 2013 | 6.18% |
| 2012 | 24.32% |
| 2011 | 122.54% |
| 2010 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 20.52% |
DE
|
|
| $40.38 | 42.84% |
JP
|
|
| $212.49 | 24.09% |
CH
|
|
| $19.19 | -0.09% |
IN
|
